A. Bravo Molina

Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm

Jorge Parra-Ruiz, A. Bravo Molina, Alejandro Peña-Monje et al. · Journal of Antimicrobial Chemotherapy · 2012 · 74 citations · Full text

High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation

A. Bravo Molina, Rosa del Campo, Luís Máiz et al. · Journal of Antimicrobial Chemotherapy · 2008 · 68 citations

Inter-observer agreement of the Wagner, University of Texas and PEDIS classification systems for the diabetic foot syndrome

A. Bravo Molina, J.P. Linares Palomino, Blanca Vera-Arroyo et al. · Foot and Ankle Surgery · 2016 · 55 citations

Inter-observer Agreement, Pedis Classification Systems, Diabetic Foot Syndrome +8

Influence of wound scores and microbiology on the outcome of the diabetic foot syndrome

A. Bravo Molina, J.P. Linares Palomino, S. Lozano Alonso et al. · Journal of Diabetes and its Complications · 2015 · 23 citations

Diabetic Foot Syndrome, Diabetes, Lower Extremity Wound +7